Occlusion Versus Pharmacologic Therapy for Moderate Amblyopia

Completed · Phase 3

Conditions studied: Amblyopia

In brief

* To determine whether the success rate with drug treatment (atropine) of amblyopia due to strabismus or anisometropia in patients less than 7 years old is equivalent to the success rate with occlusion (patching) therapy * To develop more precise estimates of the success rates of amblyopia treatment * To identify factors that may be associated with successful treatment of amblyopia * To collect data on the course of treated amblyopia to provide more precise estimates of treatment effects than are now available Extended Follow up of Study Patients * Primary: To determine the long-term visual acuity outcome at age 10 years and at age 15 years in patients diagnosed with amblyopia before age 7 years. * Secondary: To determine whether the long-term visual acuity outcome at age 10 years and at age 15 years differs between patients who received patching followed by best clinical care and patients who received atropine followed by best clinical care

Key facts

Study ID

NCT00000170

Run by

Jaeb Center for Health Research

People needed

419

Starts

1999-04-01

Expected to finish

2013-08-01

Last updated by the study team

2014-03-06

Who can join

Age: any, up to 6. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients must be 7 years old or younger with amblyopia due to strabismus or anisometropia
• Visual acuity in the amblyopic eye must be between 20/40 and 20/100
• Visual acuity in the sound eye or 20/40 or better
• At least 3 lines of acuity difference between the two eyes

You may not qualify if…

• More than two months of amblyopia therapy in the past two years
• Myopia (more than -0.50 D)

Where it is running

• Wilmer Eye Institute — Baltimore, Maryland, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.